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A major obstacle impeding malaria research has been the lack of an in vitro system 
capable of supporting infection through the entire liver stage cycle of the parasite, 
including that of the dormant form known as hypnozoites. Primary hepatocytes lose 
their specialized functions in long-term in vitro culture. The malaria parasite 
Plasmodium initiates infection in hepatocyte. This corresponds to the first step of 
clinically silent infection and development of malaria parasite Plasmodium in the 
liver. Thus the liver stage is an ideal target for development of novel antimalarial 
interventions and vaccines. However, drug discovery against Plasmodium liver stage 
is severely hampered by the poor understanding of host-parasites interactions during 
the liver stage infection and development. In this study, we have performed tandem 
mass tags (TMT) labelling based quantitative proteomic analysis in simian primary 
hepatocytes cultured in three different systems of susceptibility to Plasmodium 
infection. Our results display potential candidate molecular markers including 
asialoglycoprotein receptor (ASGPR), apolipoproteins, squalene synthase and 
scavenger receptor B1 (SR-BI) that facilitate productive infection and full 
development in relapsing Plasmodium species. The identification of these candidate 
proteins required for constructive infection and development of hepatic malaria liver 
stages paves the way to explore them as therapeutic targets. 
Statement of study significance 
Current malaria control and elimination tools such as dug treatments are not 
targeting hypnozoites of P. vivax and P. ovale. This hypnozoite reservoir is a hurdle 
to achieve disease elimination goals. The objective of this current study is to identify 
and comprehensively characterize host molecular factors facilitating relapsing 
Plasmodium infection and development to enable malaria liver stages including 
hypnozoite active compounds rapid drug discovery. Our current data revealed 
candidate proteins required for constructive Plasmodium parasite infection and 
development to establish in the liver. This should now facilitate development of cell 
lines permissive to hypnozoite producing malaria parasites that would be used for 
high throughput screen of hypnozoite cidal compounds. Discovery of such malaria 
interventions would significantly support global malaria effective control and 
elimination. Disease control and elimination are important for national poverty 
reduction strategies in malaria-endemic countries because of the social and 
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economic impacts of malaria. Our study would be of interest to the clinical, drug 
discovery and basic research malaria communities as it could help understand the 
interplay between the host and the parasite. The study could also be useful for the 
discovery and development of novel vaccines and therapeutic candidates against 
relapsing malaria 
Introduction: 
Malaria was estimated to cause over 219 million infections resulting in approximately 
435,000 deaths annually[1]. Global elimination of P. vivax and P. ovale is hampered 
due to several bottlenecks. Most notably, P. vivax and P. ovale produce a quiescent 
hepatic form “hypnozoites” that are responsible for malaria relapses[2] At present, 
there is no safe available treatment to tackle hypnozoite induced relapse.  The issue 
of relapse is compound by lack of an adequate continuous in vitro cultivation system 
for the hepatic stage of the parasite, rendering developing a basic understand of the 
parasite’s biology an arduous process. Currently, primaquine and tafenoquine are 
the only licensed drugs available in the market that could curtail the hypnozoite 
reservoir[3]. However, both drugs have serious toxicity liabilities and unsuitable for 
widespread use. This is a major hurdle to successful disease elimination[4]. As such, 
there is a growing need to develop new anti-hypnozoitocidal compounds to tackle 
this reservoir of the parasite and prevent malaria relapses. In the last decade, a 
number of new compounds have entered the antimalarial pipeline, most of which 
originated from high throughput screens on the asexual blood stage of P. falciparum, 
a malaria parasite that does not form hypnozoites[5]. This is because the 
development of liver stage screens entails a number of biological and logistical 
obstacles. The primary hepatocytes rapidly loses their liver specialized functions 
when grown under in vitro conditions on collagen coated plates[6]  and hepatic cell 
lines lack many cellular functions of their in vivo counter parts that enable P. vivax to 
complete the liver-stage cycle.  Furthermore, as hypnozoites do not multiply and 
infect new cell, the number of infected hepatocytes become diluted as cell lines 
continue to double. Physiological and functional features of primary hepatocytes can 
be retained to some extend when using matrigel, a protein extract from Engelbreth-
Holm-Swarm mouse sarcoma cells[7]. Due to the difficulties in culturing hepatocytes 
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in vitro, only few studies have been undertaken to investigate the liver stage biology 
of relapsing parasites[8] [9] [10] and host hepatocyte-parasite interactions.  
A number of host-cell receptors associated with Plasmodium liver-stage sporozoites 
infection of hepatocytes have been identified. The tetraspanin CD81[11] has been 
shown to be essential in human P. falciparum and rodent P. yoelii sporozoites 
infection. Likewise, scavenger receptor B1 (SR-BI) enhances hepatocytes 
permissiveness to Plasmodium infection and is shown to be critical for Plasmodium 
liver stage development[12] [13]. Interaction between heparan sulfate proteoglycans 
and Plasmodium circumsporozoite protein (CSP) triggers the host invasion signal in 
Plasmodium sporozoites and promote host cells entry[14]. Overexpression of host 
receptor liver-fatty acid binding protein (L-FABP) has been shown to promote liver 
stage malaria parasite growth[15]. Recently, the ephrin type-A receptor 2 (EphA2) 
was shown to be associated with the onset of productive invasion and development 
by the malaria parasite[16]. However, none of these receptors have been reported to 
be associated with the liver stages of Plasmodium relapsing species infection and 
development.   
To better understand host-parasite interactions, we have set out to analyse the host 
proteome using a tandem mass tags (TMT) based quantitative proteomic analysis of 
simian primary hepatocytes cultured under conditions permissive and inhibitory of 
Plasmodium liver infection and development. In the process, we identified the 
asialoglycoprotein receptor (ASGPR), apolipoproteins, and scavenger receptor B1 
(SR-BI) as key component for constructive infection of the hepatocyte. Several of the 
up-regulated proteins observed in Plasmodium permissive cells culture conditions 
include previously identified specialized receptors in binding and entry of other 
pathogens. Additionally, a number of proteins involved in diverse biosynthetic 
pathways including cholesterol biosynthesis were up regulated in cells permissive to 
Plasmodium infection. Taken together, our data displayed that multiple proteins are 
required for a constructive Plasmodium parasite infection and development to 
establish. The definitive role of each individual protein for malaria parasite 
constructive infection and development remains to be investigated. However, 
identification of these important candidate proteins during malaria liver stage 
infection could help understand the interplay between the host hepatic cells and the 
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malaria parasite and could potentially be useful for the discovery and development of 
novel vaccines and therapeutic candidates against relapsing malaria.  
Material and Experimental Procedures: 
Ethical committees and animal welfare. Simian hepatocytes were isolated from 
segments of liver taken from healthy Macaca fascicularis monkeys provided by the 
institutions, Novartis Laboratory of Large Animal Services, New Jersey, U.S.A., 
(Novartis-LAS); and SingHealth, Singapore. The Armed Forces Research Institute of 
Medical Sciences, Bangkok, Thailand (AFRIMS) provided Macaca fascicularis 
monkeys that were used for sporozoites production were from The Armed Forces 
Research Institute of Medical Sciences, Bangkok, Thailand (AFRIMS). Prior to 
commencement of the study; Novartis Animal Welfare first evaluated and certified all 
institutions. The collection and use of materials were performed in accordance with 
the recommendations of the Association for the Assessment and Accreditation of 
Laboratory Animal Care (AAALAC) Standards and the Guide for the Care and Use of 
Laboratory Animals. Efforts were made to minimize discomfort of all animals. All 
experiments with animal were approved by the “Novartis Institutional Animal Care 
and Use Committees”, prior to the study start. This project was reviewed for 
compliance with all established regulatory and accreditation standards at AFRIMS. 
AFRIMS’ Institutional Animal care and Use Committee (IACUC) reviewed and 
approved that the project was in line with the humane animal care and use standards 
expressed in the Guide for the Care and Use of Laboratory Animals (National 
Research Council, 2011), the Ethical Principles and Guidelines for the Use of 
Animals for Scientific Purposes (National Research Council of Thailand, 2006) and 
Animal for Scientific Purposes Act 2015. Any noncompliance issues are reported to 
the AFRIMS Director as well at the Office of Laboratory Animal Welfare, National 
Institutes of Health, Washington D.C., USA. All animals used in this study are 
maintained in a facility that is fully accredited by the Association for the Assessment 
and Accreditation of Laboratory Animal Care International (AAALAC International). 
Environmental conditions were also maintained as recommended in the Guide for 
the Care and Use of Laboratory Animals. The United States Army Medical 
Directorate, Armed Forces Research Institute of Medical Sciences (USAMD-
AFRIMS) IACUC and the Animal Use Review Division, U.S. Army Medical Research 
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and Materiel Command reviewed and approved the animals used in these studies 
under the Protocol Number PN13-06, in accordance with established principles 
under the Guide for the Care and Use of Laboratory Animals (ILAR, 2011). The 
USAMD-AFRIMS Animal Care and Use Program has been considered an excellent 
accredited program by Association for Assessment and Accreditation for Laboratory 
Animal Care (AAALAC) International. In SingHealth animal were housed in 
accordance with the recommendations of the Association for the Assessment and 
Accreditation of Laboratory Animal Care International (AAALAC) Standards and with 
the recommendations in the Guide for the Care and Use of Laboratory Animals. All 
animals discomfort was minimized and projects reviewed by SingHealth 
Experimental Medicine Centre (SEMC) prior to the Institutional Animal Care and Use 
Committee (IACUC). IACUC Ref No.: 2015/SHS/1024 SingHealth IACUC Secretariat 
@ SingHealth Office of Research. 
 
Parasites:   
P. cynomolgi (B strain) sporozoites were obtained from infected Anopheles dirus. 
Salivary glands were collected 14-30 days after a blood meal from an infected 
monkey. Infected salivary glands were removed and sporozoites were recovered as 
previously reported [4]. All P. cynomolgi infected A. dirus mosquitoes were obtained 
from USAMD-AFRIMS, Bangkok 10400, Thailand.  
Primary hepatocyte isolation and culture conditions (FMD1, SGD7 and OMD7) 
establishment:  
Simian primary hepatocytes were isolated from segments of liver collected from 
healthy Macaca fascicularis as previously described [6, 10]. Hepatocytes were cultured 
in complete media: William's Medium E (Life Technologies) supplemented with 10% 
Fetal Clone II serum (ref: SH30066.03), 5 × 10−5 M water soluble hydrocortisone 
(Sigma, H0396), 5 μg per ml insulin (Sigma), 2 mM L-glutamine and 200 U per ml 
penicillin, 200 μg per ml streptomycin (Life Technologies). Hepatocytes were seeded 
at a final cell density of 250,000 cells per cm2 in 96 wells (Greiner bio One, 655956) 
and 48-well (Nest Scientific 748001) plates coated with collagen (SIGMA-MERCK # 
11179179001). Hepatocytes were cultured in three conditions as depicted in the 
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schematic diagram in figure 1. All three samples were incubated in 5% CO2 at 37°C.  
The three culture conditions are as follows: Condition 1: fresh monolayer day 1 
(FMD1), corresponding to freshly isolated hepatocytes cultured in collagen coated 
plate for one day. Condition 2: sandwich gel day 7 (SGD7), consisting of FMD1 
overlaid with matrigel (BD Biosciences) at (t = D 1), forming a culture sandwich 
collagen-matrigel and cultured for seven days. Condition 3: old monolayer day 7 
(OMD7), consisting of FMD1 cultured for seven days in monolayer (collagen 
monolayer without Matrigel overlaid). Culture conditions were infected with P. 
cynomolgi sporozoites (figure 1 A) for parasite infectivity and developments 
assessment. Uninfected cultures (figure 1 B) were used to identify potential host 
proteins that aid in establishing P. cynomolgi infection. Culture condition FMD1 was 
infected with P. cynomolgi sporozoites at time D1 and ended at time D7; while SGD7 
and OMD7 were infected with P. cynomolgi sporozoites at time D7 then ended at 
time D14 (figure 1A). Uninfected cultures were collected at time D1 for FMD1 and at 
time D7 for SGD7 and OMD7 for proteomic analysis (figure 1B). 
Infection and parasite quantification: 
Three million (3,000,000) sporozoites /ml of P. cynomolgi were re-suspended in the 
above complete medium used for hepatocyte culture to infect cultures in 96 well 
plates (60,000 sporozoites in 50 µl/well). The infected culture plates were centrifuged 
for 10 min at 2000 rpm, allowing fast parasite sedimentation, followed by incubation 
incubated at 37°C with 5% CO2. At 3 hours post infection, the medium was removed, 
hepatocytes were washed three times and fresh media was added back to the 
cultures and the infected hepatocytes  incubated at 37°C, 5% CO2. Matrigel (BD 
Biosciences) was added as per the manufacturer's recommendations. The medium 
was refreshed every 48 hours. At defined time points shown in figure 1, the cultures 
were fixed with 100% cold methanol for 3 min (figure 1) for imaging. Pre-erythrocytic 
(Hypnozoite: Hyp, Schizont: Schz and bursting Schizont: Bur Schz) parasites were 
detected by immunofluorescence. Following fixation, the cultures plates were 
specifically stained with a rabbit anti-P. cynomolgi HSP70 (Genscript 299349-3, 
1:5,000) and a mouse anti-P. cynomolgi UIS4 polyclonal antibodies (1:200) for 1 
hour incubation at 37°C with the antibodies diluted 1:5,000 and 1:200 in 1X PBS 
respectively for HSP70 and UIS4. Binding was visualized with (red) Alexa 594-
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conjugated goat anti-mouse immunoglobulin for US4 (ref 11032 Invitrogen) and 
(green) Alexa 488-conjugated goat anti-rabbit immunoglobulin for HSP70 (ref 11034 
Invitrogen). Parasite and cell nuclei were stained with 1 μg per ml of DAPI (Sigma). 
Parasites were enumerated under a fluorescence microscope with a 40X 
magnification and images were obtained from NIKON ECLIPSE TS100 microscope. 
GraphPad Prism software and ANOVA Statistical test were used to compare the 
infectivity of the different cell culture conditions and the parasite development. The 
populations compared were derived from three independent biological replicates. A p 
-value of 0.05 or less was considered to be statistically significant.  
 
Sample collection and protein extraction: 
Samples from SGD7, FMD1 and OMD7 cultures were collected at the defined time 
points shown in figure 1. The culture medium was removed and the cells were 
washed thrice with PBS. The cells were lysed in 100 μl lysis buffer (2% SDS, 100 
mM Tris-HCl [pH 7.4], 1μM dithiothreitol (DTT), Protease inhibitor cocktail) by 
sonication at 40% amplitude for 1min. Insoluble cell debris were removed by 
centrifugation at 20000×g for 10 min at 4oC. The protein samples were purified by 
acetone precipitate. The purified protein pellets were reconstituted in 250 µl urea 
buffer (8 M urea and protease inhibitor cocktail in 100 mM ammonium bicarbonate 
buffer (ABB), pH 8). Protein amount of each sample was measured by BCA based 
protein quantitation method.  
In-solution protein digestion and TMT (Tandem mass tags) labelling: 
One-hundred μg equivalent amount of protein from each sample was taken and used 
for subsequent proteomic experiment. The urea concentration of the samples was 
reduced to <1 M by diluting with 100 mM ABB and reduced with 10 mM Tris 2-
carboxyethyl phosphine hydrochloride (TCEP) at 37oC for 2 hours. Reduced samples 
were then alkylated with 20 mM Iodoacetamide (IAA) at room temperature for 45 
minutes in a dark. Protein samples were subsequently digested with trypsin at a 
trypsin-protein ratio of 1:40 overnight at 37oC. The reaction was quenched by adding 
10% TFA (final concentration of 0.4%). Tryptic peptides were desalted by using Sep-
Pak C18 cartridges (Waters, Milford, MA) and dried in a SpeedVac (Eppendrop, 
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USA). TMT labelling was performed using TMT 10-plex kits according to the 
manufacturer’s protocol (Thermo scientific, USA). The samples were labelled 
accordingly with following tags as listed in the table 1. The TMT-labelled peptides 
were pooled together and desalted.  
 
TMT labelled peptides were fractionated by reverse phase chromatography at high 
pH (~pH8). Briefly, labelled peptides were reconstituted in buffer A (0.02% NH4OH in 
water) and fractionated using X-Bridge C18 column (4.6 × 200 mm, 5 μm particle 
size, 130 Å pore size) (Waters, Milford, MA) on a HPLC unit (Prominence™, 
Shimadzu, Kyoto, Japan) at flow rate of 1ml/min. The HPLC gradient comprised 100-
95% buffer A for 3 min; 5-35% buffer B (80% ACN and 0.02% NH4OH) for 40 min; 
then 35-70% buffer B for 12min, followed by 70% buffer B for 5min. The 
chromatograms were recorded at 280 nm. A total of 60 fractions were collected 
within 65min time period. The collected fractions were combined into 15 fractions by 
using concatenated pooling strategy and concentrated to dryness using vacuum 
centrifugation. 
LC-MS/MS and data analysis: 
The LC-MS/MS analysis was performed using a Q Exactive mass spectrometer 
coupled with online nano-HPLC system (Thermo Scientific; USA). Data acquisition 
was performed using Xcalibur 2.2 software (Thermo Scientific; USA). Protein 
identification and quantification were performed using Proteome Discoverer 1.4.1.14 
(Thermo Fisher, MA) together with the Sequest search engine (parameters included 
cysteine alkylation with MMTS as static modification; methionine oxidation, and 
asparagine and glutamine deamidation as dynamic modifications; full trypsin 
digestion and maximum 2 missed and/or non-specific cleavages as digestion 
parameter; 10ppm precursor mass and 0.02 Da fragment mass tolerance). The 
NCBI proteins of Macaca fascicularis proteins (downloaded on December, 2016, 
including 73,374 sequences and 58,200,443 residues) was used as a search 
database with a cut-off false discovery rate of <0.05% and <0.01% at the peptide 
and protein level accordingly. The resulting data set was automatically bias-
corrected to eliminate potential variation due to unequal mixing when combining 
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samples. All LC-MS/MS analysis was performed in triplicate. All statistical 
calculations were performed using the biological triplet. Cluster analysis of the 
identified proteins was performed using the online bioinformatics tool Gene Pattern 
(http://genepattern.broadinstitute.org) followed by hierarchical clustering and 
Pearson correlation. 
Statistical analysis  
The quantitative proteomic results were first examined for quality using a Pearson 
correlation that showed a satisfactory linear correlation among all three biological 
replicates (n = 3) (figure 3a-b). The proteomic data distribution patterns and cut-off 
levels of statistical significance were determined using Student's t-Test and volcano 
plots (Figure 4a-c).  Distribution of the Log2 TMT ratio was used to determine the 
cut-off for the differentially regulated hits (Figure 4a). The OMD7 samples were used 
as denominator for the relative quantification conditions given that they had the least 
infections. Proteins with ratios < 0.76 (Log2Ratio < -0.4) were classified as down-
regulated hits, whereas proteins with ratios > 1.32 (Log2Ratio > 0.4) were consider 
as up-regulated hits (Figure 4a). 
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Results: 
P. cynomolgi liver stage productive infection and full development depend on 
host-cell culture conditions in vitro. 
We assessed the hepatocytes permissiveness to P. cynomolgi sporozoites infection 
through proteomic analysis of cells cultured under different conditions of 
permissiveness (Figure 1). These conditions included FMD1, OMD7 and SGD7 
described above in method section and shown in figure 1.  
Development of hepatic stages were analysed using antibodies raised against 
Plasmodium proteins HSP70 (heat shock protein 70) and UIS4 (Up-regulated in 
Infectious Sporozoite-4, a parasitophorous vacuole membrane (PVM) marker)[17]. At 
seven days post infection, P. cynomolgi (Pc) infectivity, measured with anti-
PcHSP70 antibody (green), was similar in both FMD1 and SGD7 cultures (Figure 2a 
and 2b). In contrast, infection of the OMD7 cultured hepatocytes was significantly 
lowered as compared to that in FMD1 (p = 0.0383) and SGD7 (p = 0.0006) cultures 
(Figure 2a and 2b). The diameters of the developing parasites (schizonts) were 
noticeably larger in FMD1 (p = 0.0024) and SGD7 (p = 0.0002) cultures as compared 
to that of OMD7 (Figure 2c). All the parasite stages, including hypnozoites and 
schizonts were observed in all three conditions except for the presence of mature 
bursting schizonts in OMD7 (Figure 2d). The rupture of the mature bursting schizonts 
and release of the pre-erythrocytic merozoites could be clearly discerned using the 
anti-PcUIS4 antibody (red) displaying UIS4 rupture in SGD7 and FMD1 cultures 
(Figure 2d). Our results suggest that significant productive sporozoites infection of 
the hepatocytes were only possible in the fresh (FMD1) and matrigel overlaid 
(SGD7) hepatocyte culture conditions (Figure 2a-b). Having demonstrated that the 
culture conditions of the host cells significantly pre-determine their permissiveness to 
Plasmodium sporozoites infection and parasite development; we set out to identify 
the required host molecular markers involved. 
Quantitative proteomic analysis of simian primary hepatocytes revealed 
candidate molecular markers for permissiveness to Plasmodium cynomolgi 
infection. 
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Protein samples of the three cultures conditions from three monkey donors (Figure 
1) were analysed simultaneously using tandem mass tag (TMT) quantitative 
proteomic analysis by liquid chromatograph coupled to tandem mass spectrometry 
(LC-MS/MS). The quantitative proteomic results were first examined for quality using 
a Pearson correlation that showed a satisfactory linear correlation among all the 
three biological replicates (figure 3a-b). The combined three biological replicates 
proteomic data distribution patterns and cut-off levels of statistical significance were 
determined using Student's t-Test and volcano plots (Figure 4a-c). A total of 5,763 
proteins were identified with false discovery rate (FDR) <1%, including 4,588 
proteins that incorporated more than one peptide. All the proteins and peptides 
identified are listed in the supplementary data set 1 and 2. Out of the 5,763 proteins 
identified, 1,627 were found to be non-annotated proteins. In FMD1 or OMD7 
condition, a total of 5,163 proteins follow a similar trend with less than 20% deviation 
among the three biological replicates. Under SGD7 conditions 5,012 proteins were 
identified. Further analysis focused on 2,187 proteins that were significantly enriched 
(p-value < 0.05) (Figure 4a-c and supplementary data set 1). Distribution of the Log2 
TMT ratio was used to determine the cut-off for the differentially regulated hits 
(Figure 4a). The OMD7 samples were used as denominator for the relative 
quantification conditions given that they had the least infections and would not highly 
express required proteins for successful infection. Proteins with ratios < 0.76 
(Log2Ratio < -0.4) were classified as down-regulated hits, whereas proteins with 
ratios > 1.32 (Log2Ratio > 0.4) were considered as up-regulated hits (Figure 4a). 
These criteria resulted in a total of 477 down regulated and 574 up regulated hits in 
FMD1 condition while 89 down regulated and 50 up regulated in the SGD7 culture as 
compared to OMD7 (Figure 4d). Of the hits identified in FMD1 and SGD7, there was 
an overlap of 28 up regulated and 89 down-regulated proteins respectively (Figure 
4d).  
We focused on the 28 proteins that were commonly up regulated in FMD1 and 
SGD7 samples (Figure 5, Table 2 - 4). This cluster consists of proteins involved in 
general metabolism of hepatocyte, isoprenoid, cholesterol and fatty acid 
biosynthesis, signal transduction, protein recognition, and glycoprotein surface 
receptors (Figure 5, Table 2 -4). Notably, from the up-regulated proteins dataset, we 
identified the asialoglycoprotein receptor (ASGPR) in both FMD1 and SGD7, which 
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is known to interact with other human pathogens during infection. These pathogens 
included Mycobacterium tuberculosis, Helicobacter pylori, Candida albicans, 
Leishmania spp, hepatitis C and HIV-1[18]. In addition, apolipoproteins were 
identified in this screen that have previously been reported to interact with the 
malaria parasite P. falciparum PFE1590w/ETRAMP[19]  and P. berghei 
parasitophorous vacuole membrane exported protein 1 (EXP-1) during liver-stage 
development[20]. Squalene synthase, an essential host hepatocyte enzyme required 
for sterol production[21] was also significantly up regulated in both FMD1 and SGD7. 
Previously, it has been shown that squalestatin, an squalene synthase inhibitor kills 
the blood stage Plasmodium parasites[22]. In future studies, it would be interesting to 
test its inhibitory effect on the dormant liver stage hypnozoite stage. 
Given that a single protein may not be required for the infection but rather collection 
of proteins involved in a specific pathway(s) or in a mechanism to facilitate infection 
and development, we sought to identify key pathways that allow hepatocytes to be 
permissive to infection. A pathway enrichment analysis was performed on FMD1 and 
SGD7 (Table 2 and 3) (GO and KEGG pathways).  Proteins in several pathways 
were uniquely up regulated in FMD1 samples but not in SGD7. These include 
hepatocyte developmental and metabolism related pathway, mitochondrial related 
pathways, peroxisome, and endoplasmic reticulum (Table 2). In contrast, there were 
only few pathways in which proteins were up regulated in SGD7 samples. These 
comprised pathways related to extracellular spaces of hepatocytes. The only 
pathway in which proteins were commonly up regulated in both FMD1 and SGD7 
was the extracellular exosome secretion pathway. 
Noteworthy is the observation that most of the documented host surface receptors 
required for P. falciparum sporozoites infection were not significantly altered in either 
FMD1 or SGD7 samples (Table 4) when compared to OMD7. Here, we only 
identified scavenger receptor class B member 1 (SR-B1) to be significantly up-
regulated in simian FMD1 samples, while the liver-fatty acid binding protein L-FABP 
was significantly down-regulated in both FMD1 and SGD7 samples. Further studies 
are required to test the role of SR-BI in sporozoites infection for relapsing malaria 
species. 
Discussion 
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Malaria parasites initial site of infection and development in the vertebrate host is the 
liver, however very little is known about the host molecular markers and pathways 
required for permissiveness and parasite development. Previously, four host 
receptors SR-B1[12], EphA2[16], CD81[23] and alpha-V containing integrin[24] were 
shown to be required for P. falciparum sporozoites infection to hepatocytes. 
However, none of these receptors are solely essential for P. falciparum sporozoites 
infection and development, suggesting that they interact in a mechanism that 
remains to be established. While, host receptors required for sporozoite infection and 
development of the liver stage cycle have been comprehensively characterized in P. 
falciparum and rodent malaria species. No receptor for the liver stage has been 
identified and reported for relapsing parasites; receptors required for relapsing 
parasites P. vivax and P. ovale remain elusive. The current study aims to identify 
candidate proteins potentially required in relapsing parasites infection and 
development. We report that the above known receptors for malaria entry in liver 
stages did not show significant changes in their expression level in all culture 
conditions. The exception was SR-BI, which was significantly up regulated in only 
FMD1 (P. value = 0.009) as compared to OMD7. Interestingly SR-BI expression level 
in FMD1 correlated with sporozoites infection rate and development in our dataset 
suggesting SR-BI role in P. cynomolgi sporozoites infection and full development.  
SR-BI is a glycosylated membrane protein present in several cell types including 
primary hepatocytes and was not up regulated in SGD7 hepatocytes. Like FMD1; 
significant infection rate and parasite full development was also found in SGD7 
samples. In agreement with other observations[12] [13]; this result suggests that SR-BI 
might play a facilitator role in the bidirectional movement of cholesterol, which is 
required for malaria parasite infection and development[11]. The ASGPR receptor has 
been identified as a common host factor involved in entry for several other infections 
of bacterial, parasitic and viral origin[25]. Here, we are the first to identify ASGPR up 
regulation in conditions conducive to permissive infection (FMD1 and SGD7) by P. 
cynomolgi sporozoites infection. ASGPR is a heterodimeric C-type lectin receptors 
expressed on the surface of hepatocyte[25] . ASGPR and SR-BI receptors have 
been reported together to bind lipoproteins[26] [27]. Other studies have shown 
apolipoprotein as important ligand for the high-density lipoprotein and SR-BI[28]. 
Apolipoprotein also interacts with malaria parasite[19] [20]. Like ASGPR, 
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apolipoprotein expression level was markedly high also only in both FMD1 and 
SGD7 but not OMD7, suggesting a potential interaction with malaria relapsing 
species. ASGPR, apolipoprotein and SR-BI could be modulators of entry and 
development of pathogens such as malaria parasite and hepatitis C virus. We also 
identified obscurin like protein and squalene synthase that were significantly up 
regulated in both FMD1 and SGD7 samples. The squalene synthase is essential for 
cholesterol biosynthesis[22], which is also required for malaria parasite and hepatitis 
C virus infection and development [11] [22]. It has been reported that there is 
interaction between mosquito titin, an ortholog of human obscurin and dengue NS3 
virus[29]. Collectively, our data suggest contribution of at least few proteins in a 
pathway or a mechanism for successful malaria parasite infection and development 
to establish.  
A significant release of extracellular exosomes was found commonly in both FMD1 
and SGD7 as compared to OMD7. Exosomes are formed from invagination of 
endosomal membranes forming vesicles that display cell surface lipids and proteins 
on their exterior face[30] . Released extracellular exosomes are shown to interact with 
target pathogens or cells through three major mechanisms: receptor-mediated 
binding, membrane fusion and nonspecific entry through the endocytic pathway[30] . 
Production of these vesicles during infection has been correlated with malaria 
severity in humans and animal[31]. Earlier studies have shown that the host 
exosomes to interact with other pathogens[30, 32].  
The overall results of this study suggest that the proteins commonly up regulated in 
FMD1 and SGD7 hepatic cells that respectively displayed significant parasite count 
(p = 0.0383 and p = 0.0006) and development (p = 0.0024 and p = 0.0002) when 
compared to OMD7 are potentially required for P. cynomolgi sporozoites productive 
infection and full development (figure 2 and figure 4d). Identifying conditions for 
human hepatocyte cultures that enable constructive malaria infection brings the field 
one step closer to establishing an in vitro system that will permit for further studies in 
hypnozoite biology and drug development. However, further thorough investigations 
are required to determine the potential role of these proteins individually or 
collectively.  
Availability of data and material 
www.proteomics-journal.com Page 17 Proteomics 
This article is protected by copyright. All rights reserved. 
17 
Dembele et al. 
The mass spectrometry proteomics raw data files along with Proteome Discoverer 
search data file (including protein summary) have been deposited to the 
ProteomeXchange Consortium (http://proteomecentral.proteomexchange.org) via the 
PRIDE partner repository[33]. ProteomeXchange provides globally coordinated 
proteomics data submission and dissemination with the dataset identifier 
PXD013310. The Reviewer account details is Username: eviewer54597@ebi.ac.uk 
and Password: W6fipGrM. The proteins and peptides information from Proteome 
Discoverer search are available in the supplementary data set 1 and 2. 
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Figure 1. Study procedure schematic diagram. A) Cultures infected with P. 
cynomolgi sporozoite and used for parasite infectivity and developments assessment 
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in FMD1, OMD7 and SGD7 conditions. B). Cultures not infected, used for proteomic 
study to assess host cells candidate markers required for parasite infectivity and 
developments in FMD1 and SGD7 when compared OMD7. FMD1 consists of fresh 
monolayer day 1 cultures; OMD7 is old monolayer day 7 cultures and SGD7 is 
sandwich gel overlaid cultures day 7. In A) images, green correspond to P. 
cynomolgi anti-heat shock protein 70 (Pc-anti HSP70), red is parasite UIS4 and bleu 
is DAPI corresponding to parasite and hepatocytes nuclei. 
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Figure 2. P. cynomolgi liver stage productive infection and full development depend 
on host cell culture conditions. A) Average count of exo-erythrocytic forms (EEF) of 
P. cynomolgi in SGD7, FMD1 and OMD7 at day seven post infection; B) 10X 
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immune-fluorescence images of EEF of P. cynomolgi in SGD7, FMD1 and OMD7. C) 
diameter of EEF of P. cynomolgi diameter in SGD7, FMD1 and OMD7 and D) 40X 
immune-fluorescence images of EEF of P. cynomolgi in SGD7, FMD1 and OMD7. P. 
cynomolgi anti-heat shock protein 70 (Pc-anti HSP70) labeled parasites in Green. P. 
cynomolgi anti UIS4 (PC-antiUIS4) labeled parasites in red. DAPI labeled nuclei of 
hepatic cell and parasites is in blue. The graph bar in figure 2A and 2C are derived 
from three independent biological assays. 
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Figure 3. Scatter plot of differentially expressed proteins between biological 
replicates for SGD7 and FMD1 samples. The x-axis and y-axis represents the log2 
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fold change data.  Scatter plot showing the tight positive correlation among 3 
biological replicates for A) FMD1 samples and B) SGD7 samples. 
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Figure 4. A) Frequency distribution plot of Log2TMT ratio. B-C) Volcano plot 
highlighting significantly differentially regulated proteins for SGD7 and FMD1 
samples. Every data point in the volcano plot serves as fold change difference 
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between FMD1 and OMD7 B) and between SGD7 and OMD7 C) plotted against 
their respective p-values. The x-axis represents the log2 fold change whereas the y-
axis is the -log10 p-values. D) Venn diagram showing the proteins that were 
differentially expressed in FMD1 and SGD7 samples. Up-regulated hits (red) and 
down-regulated hits (blue). There are 117 proteins that are commonly regulated in 
both FMD1 and SGD7 samples. This is from combined three biological replicates 
proteomic data. 
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Figure 5. Hierarchical clustering of up- and down-regulated genes in FMD1 and 
SGD7 as compared to OMD7 for three biological replicates is shown.  Red are up-
regulated genes, white are non-affected genes and green are down-regulated genes. 
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Table 2. Pathway enrichment for up-regulated genes in Fresh monolayer day 1 
(FMD1) compared to old monolayer day 7 (OMD7). Nine hundred and five up-
regulated genes of FMD1 samples were analysed and significantly enriched 
pathways using GO and KEGG database. Selected pathways related to liver stage 
development and metabolism is shown (Go and KEGG pathways). Number of genes 
and the receptive p-value for each pathway in our dataset is also included (p-value < 
0.05). 
 
Pathway name in (FMD7 and OMD7) 
Number of 
genes 
 P- value 
Metabolic pathways 99 2.6763E-39 
cytosol 92 8.37E-13 
extracellular exosome* 83 8.47146E-13 
oxidation-reduction process 40 8.95E-16 
mitochondrial matrix 38 8.29E-24 
developmental 34 3.11E-02 
endoplasmic reticulum membrane 28 3.46346E-05 
aging 24 0.026212652 
mitochondrial inner membrane 22 5.12E-07 
intracellular membrane-bounded organelle 21 6.23758E-05 
Peroxisome 14 1.86E-08 
response to drug 13 1.42E-03 
electron carrier activity 13 4.41E-09 
receptor binding 13 4.17E-03 
Carbon metabolism 13 4.93036E-06 
Valine, leucine and isoleucine degradation 13 1.7696E-10 
Chemical carcinogenesis 12 9.46E-07 
liver development 6 4.06E-03 
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Table 3. Pathway enrichment for up-regulated genes in sandwich gel day 7 
(SGD7) compared to old monolayer day 7 (OMD7). A hundred and nineteen up-
regulated genes of SGD7 samples were examined and significantly enriched 
pathways were highlighted using GO and KEGG database. Pathways that were 
significantly enriched are shown here. Number of genes and the receptive p-value 
for each pathway in our dataset is also included (p- value < 0.05). 
 
 




 P- value 
extracellular space 6 0.007732 
extracellular exosome* 8 0.037245 
extracellular matrix structural constituent 3 0.001995 
Complement Clr-like EGF domain 2 0.028201 
Epidermal growth factor-like domain 3 0.0312 
Pathways in cancer 5 0.009017 
Small cell lung cancer 3 0.01434 
ECM-receptor interaction 3 0.015331 
Toxoplasmosis 3 0.025922 
EGF 3 0.024899 
Disulfide bond 7 0.001946 
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Table 4. List of hepatocyte surface receptors known for pre-erythrocytic stage 











XP_005576959.1 CD81 antigen isoform X2 0.323 0.012 0.126 0.144 
XP_005587354.1 Basigin isoform X1 0.063 0.245 0.048 0.345 
XP_005572655.1 
Scavenger receptor class 
B member 1 isoform X5 0.703 
0.009
* 0.123 0.186 
XP_005570076.1 
Scavenger receptor 
cysteine-rich type 1 
protein M130 isoform X4 -0.226 0.123 -0.207 0.023 
XP_005563674.1 
Fatty acid-binding 






Ephrin type-A receptor 1 
isoform X3 -0.333 0.118 -0.267 0.036 
XP_005549301.1 
Transferrin receptor 
protein 2 isoform X2 
(CD71) 0.575 0.11 0.148 0.003 
 
 * Significantly differentially expressed in FMD1 samples (Cut off: greater than or less 
than 0.4, p-value < 0.05). 
 ** Significantly differentially expressed in SGD7 samples (Cut off: greater than or 
less than 0.4, p-value < 0.05). 
